BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38480640)

  • 1. Sclerotherapy with 3% polidocanol foam for the treatment of mucocutaneous bridges and/or residual piles after open excisional hemorrhoidectomy.
    Gallo G; Laforgia R; Goglia M; Lobascio P
    Updates Surg; 2024 Mar; ():. PubMed ID: 38480640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
    Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P
    Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary Results of the First 50 Patients Undergoing Sclerotherapy for II-Degree Hemorrhoidal Disease Using an Automated Device.
    Goglia M; Nigro C; Aurello P; Diaco E; Trompetto M; Gallo G
    Front Surg; 2022; 9():882030. PubMed ID: 35495738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM).
    Gallo G; Pietroletti R; Novelli E; Sturiale A; Tutino R; Lobascio P; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Luc AR; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; Sammarco G
    Tech Coloproctol; 2022 Aug; 26(8):627-636. PubMed ID: 35334004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Results of Sclerotherapy with 3% Polidocanol Foam for Symptomatic Second- and Third-Degree Hemorrhoidal Disease.
    Lobascio P; Laforgia R; Novelli E; Perrone F; Di Salvo M; Pezzolla A; Trompetto M; Gallo G
    J Invest Surg; 2021 Oct; 34(10):1059-1065. PubMed ID: 32290709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal Open Hemorrhoidectomy Versus Transanal Hemorrhoidal Dearterialization: The Effect on Symptoms: An Open-Label Randomized Controlled Trial.
    Rørvik HD; Campos AH; Styr K; Ilum L; McKinstry GK; Brandstrup B; Olaison G
    Dis Colon Rectum; 2020 May; 63(5):655-667. PubMed ID: 31996581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-term efficacy and postoperative wound management of laser hemorrhoidoplasty (LHP) vs conventional excisional hemorrhoidectomy in grade III hemorrhoidal disease: the twisting trend.
    Gambardella C; Brusciano L; Brillantino A; Parisi S; Lucido FS; Del Genio G; Tolone S; Allaria A; Di Saverio S; Pizza F; Sturiale A; Docimo L
    Langenbecks Arch Surg; 2023 Apr; 408(1):140. PubMed ID: 37020091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excisional Hemorrhoidectomy Versus Dearterialization With Mucopexy for the Treatment of Grade III Hemorrhoidal Disease: The EMODART3 Multicenter Study.
    Giuliani A; Romano L; Necozione S; Cofini V; Di Donato G; Schietroma M; Carlei F;
    Dis Colon Rectum; 2023 Dec; 66(12):e1254-e1263. PubMed ID: 37616177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal Doppler-guided transanal hemorrhoidal dearterialization with mucopexy versus conventional hemorrhoidectomy for grade III and IV hemorrhoids: postoperative morbidity and long-term outcomes.
    Trenti L; Biondo S; Galvez A; Bravo A; Cabrera J; Kreisler E
    Tech Coloproctol; 2017 May; 21(5):337-344. PubMed ID: 28451767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term Outcomes of Transanal Hemorrhoidal Dearterialization With Mucopexy Versus Vessel-Sealing Device Hemorrhoidectomy for Grade III to IV Hemorrhoids: A Prospective Randomized Multicenter Trial.
    Trenti L; Biondo S; Kreisler Moreno E; Sanchez-Garcia JL; Espin-Basany E; Landaluce-Olavarria A; Bermejo-Marcos E; Garcia-Martinez MT; Alías Jiménez D; Jimenez F; Alonso A; Manso MB;
    Dis Colon Rectum; 2019 Aug; 62(8):988-996. PubMed ID: 30807456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study.
    Salgueiro P; Rei A; Garrido M; Rosa B; Oliveira AM; Pereira-Guedes T; Morais S; Castro-Poças F
    Tech Coloproctol; 2022 Aug; 26(8):615-625. PubMed ID: 35217937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excisional hemorrhoidal surgery and its effect on anal continence.
    Li YD; Xu JH; Lin JJ; Zhu WF
    World J Gastroenterol; 2012 Aug; 18(30):4059-63. PubMed ID: 22912558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polidocanol Foam Sclerotherapy Versus Rubber Band Ligation in Hemorrhoidal Disease Grades I/II/III: Randomized Trial.
    Salgueiro P; Garrido M; Santos RG; Pedroto I; Castro-Poças FM
    Dis Colon Rectum; 2022 Jul; 65(7):e718-e727. PubMed ID: 34840294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes.
    Pata F; Bracchitta LM; D'Ambrosio G; Bracchitta S
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumferential excisional hemorrhoidectomy for extensive acute thrombosis: a 14-year experience.
    Mukhashavria GA; Qarabaki MA
    Dis Colon Rectum; 2011 Sep; 54(9):1162-9. PubMed ID: 21825898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LONG TERM RESULTS AFTER STAPLED HEMORRHOIDOPEXY ALONE AND COMPLEMENTED BY EXCISIONAL HEMORRHOIDECTOMY: A RETROSPECTIVE COHORT STUDY.
    Araujo SE; Horcel LA; Seid VE; Bertoncini AB; Klajner S
    Arq Bras Cir Dig; 2016; 29(3):159-163. PubMed ID: 27759778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative discomfort and pain in the management of hemorrhoidal disease: laser hemorrhoidoplasty, a minimal invasive treatment of symptomatic hemorrhoids.
    Brusciano L; Gambardella C; Terracciano G; Gualtieri G; Schiano di Visconte M; Tolone S; Del Genio G; Docimo L
    Updates Surg; 2020 Sep; 72(3):851-857. PubMed ID: 31760588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR).
    Gallo G; Di Saverio S; Clerico G; Sturiale A; Manigrasso M; Luc AR; Trompetto M; Sammarco G;
    BMC Surg; 2020 Oct; 20(1):251. PubMed ID: 33092570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Sectorial Longitudinal Augmented Prolapsectomy for Asymmetric Muco-hemorrhoidal Prolapse: An Observational Study of 433 Consecutive Patients.
    Landolfi V; Brusciano L; Gambardella C; Tolone S; Del Genio G; Grossi U; Gualtieri G; Lucido FS; Docimo L
    Surg Innov; 2022 Feb; 29(1):27-34. PubMed ID: 33830810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excisional Hemorrhoidectomy: Safe in Patients With Crohn's Disease?
    Lightner AL; Kearney D; Giugliano D; Hull T; Holubar SD; Koh S; Zaghiyan K; Fleshner PR
    Inflamm Bowel Dis; 2020 Aug; 26(9):1390-1393. PubMed ID: 31633186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.